NSC-526417

Known as: NSC 526417, NSC526417 
 

Topic mentions per year

Topic mentions per year

1983-1992
01219831992

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1993
1993
The objective of this trial was to determine the efficacy of echinomycin (1.2mg/m2) administered on a weekly times four schedule… (More)
  • table 1
Is this relevant?
1992
1992
Eighteen evaluable patients with recurrent or metastatic nonsquamous carcinoma of the uterine cervix were treated with 1,500… (More)
Is this relevant?
1992
1992
Nineteen evaluable patients with recurrent or metastatic squamous cell carcinoma of the uterine cervix were treated with 1,500μg… (More)
  • table 1
Is this relevant?
1990
1990
Twenty-eight evaluable patients with advanced or recurrent squamous-cell carcinoma of the cervix were treated with 1,500… (More)
Is this relevant?
1990
1990
Twenty-two patients with recurrent carcinoma of the ovary progressive after initial chemotherapy (21 with cisplatin-based… (More)
Is this relevant?
1989
1989
Echinomycin was administered to 43 patients with advanced cancer in escalating doses ranging from 60 to 2128 mcg/m2. The dose… (More)
Is this relevant?
1983
1983
The potential clinical activity of the new phase I drugs N-methylformamide (N-MF) and Echinomycin (ECH) was examined while still… (More)
  • table 1
  • table 2
  • table 3
Is this relevant?